Skip to main content
Clinical Trials/CTRI/2025/10/096438
CTRI/2025/10/096438Not yet recruitingPhase 3

The effect of high-frequency rTMS on alcohol craving – Results from a double-blinded randomized sham-controlled trial

Department of Psychiatry1 site in 1 country40 target enrollmentStarted: November 3, 2025Last updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Enrollment
40
Locations
1
Primary Endpoint
Reduction in alcohol craving

Study Overview

Brief Summary

High-frequency rTMS will be applied over the right prefrontal cortex (rPFC). Alcohol craving measured using the Alcohol Craving Questionnaire (ACQ)****-SF-R, tolerability and feasibility of administering rTMS and Alcohol use patterns, including abstinence duration, and relapse episodes via Time Line Follow Back method- alcohol (TLFB- Alcohol) will be assessed across five timepoints: baseline, post-treatment, one-month, three-month and six-month follow-up, compared to sham rTMS.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
Participant and Outcome Assessor Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Adults more than or equal to 18 years with ICD 11 diagnosis of Alcohol Dependence.
  • Patients not in active withdrawal that is, CIWA-Ar less than or equal to 10 at enrollment.
  • Right-handed and willing to stay for 10-day intervention.
  • Provided written informed consent.

Exclusion Criteria

  • History of seizures, epilepsy, or neurological conditions.
  • Implanted metal devices or medications lowering seizure threshold.
  • Severe psychiatric comorbidity like schizophrenia, BPAD etc,.
  • Pregnancy, lactation, or concurrent substance dependence.

Outcomes

Primary Outcomes

Reduction in alcohol craving

Time Frame: alcohol craving, measured using the Alcohol Craving Questionnaire (ACQ)-SF-R, across five timepoints: baseline, post-treatment, one-month, three-month and six-month follow-up, compared to sham rTMS.

Secondary Outcomes

  • tolerability and feasibility of administering rTMS, alcohol use pattern post-intervention.(baseline, post-treatment, one-month, three-month and six-month follow-up)

Investigators

Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Vijeyta N

Government Stanley medical college and hospital

Study Sites (1)

Loading locations...

Similar Trials